Vor Bio

Vor Bio is a cell and genome engineering biotechnology company focused on curing blood cancers. They aim to achieve this through their approach of "shielded transplants," which aims to protect healthy cells while exposing cancer cells to potentially curative treatments. Vor Bio's proprietary platform utilizes HSEC biology, genome engineering, and CAR-T cells to develop innovative therapies for patients with AML and other blood cancers.